The controversial presidential election has garnered lots of attention and Google searches, revealing an engaged electorate that is still actively seeking information leading up to Election Day on November 8. During the presidential debate on Monday alone, Google reported that there was a surge of 100,000 searches for the phrase "register to vote" in Spanish.
NACDS co-hosted its inaugural Test2Learn™ Community-Based Pharmacogenomics Certificate Program with the University of Pittsburgh this week. NACDS and the University of Pittsburgh School of Pharmacy adapted Test2Learn ™ from an innovative University platform that enables students to learn by using real genetic data in highly-interactive exercises.
Sixteen individuals from NACDS member companies – including chains and associates – are featured in Fortune magazine’s September 15 edition, in its lists of the most powerful women.
We forecast that Gen Zers will establish themselves as a highly demanding consumer base.
As Election Day fast approaches, a series of upcoming presidential debates will offer an excellent opportunity to gain pivotal insights into the presidential candidates as they face off against one another.
NACDS has long been committed to curbing and preventing opioid abuse, most recently backing legislation—the Comprehensive Addiction and Recovery Act (CARA) and the Ensuring Patient Access and Effective Drug Enforcement Act—which were both signed into law by the president this year.
…The Association and its members are stepping up to an enlarged set of responsibilities as healthcare providers, businesses and citizens. This bodes well for the industry, the people it serves and the country.
NACDS is joining the Centers for Disease Control and Prevention (CDC) and the National Foundation for Infectious Diseases (NFID) to promote the importance of everyone in the U.S. six months and older getting the flu vaccine. The campaign will use the hashtag #FightFlu to raise awareness on social media channels.
An article in the distinguished peer-reviewed health journal Health Affairs last week reported on an NACDS-supported study that found patients’ enrollment in Medicare Part D medication therapy management (MTM) programs varies according to the program’s eligibility criteria.